Cargando…

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma

BACKGROUND: PD-L1 expression levels determined by immunostaining are known to be related to the survival rate and prognosis of patients with various types of cancers, as well as to the therapeutic response to immune checkpoint inhibitors. Recently, the U.S. Food and Drug Administration approved an i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ki Hyung, Choi, Kyung Un, Kim, Ahrong, Lee, So Jung, Lee, Jung Hee, Suh, Dong Soo, Kwon, Byung-su, Hwang, Chungsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580633/ https://www.ncbi.nlm.nih.gov/pubmed/31208449 http://dx.doi.org/10.1186/s13048-019-0526-0

Ejemplares similares

Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma
por: Hwang, Chungsu, et al.
Publicado: (2019)

Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma
por: Choi, Kyung Un, et al.
Publicado: (2020)

The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma
por: Hwang, Chungsu, et al.
Publicado: (2023)

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
por: Martin de la Fuente, Laura, et al.
Publicado: (2020)

Gastrointestinal tract spindle cell tumors with interstitial cells of Cajal: Prevalence excluding gastrointestinal stromal tumors
por: Lee, So Jung, et al.
Publicado: (2016)

Lymphocyte-activating gene-3 expression is associated with tumor-infiltrating lymphocyte levels in HER2-positive breast cancers
por: Lee, Seokwon, et al.
Publicado: (2021)

Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
por: Kim, So Young, et al.
Publicado: (2019)

Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
por: Kim, Ahrong, et al.
Publicado: (2017)

Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma
por: Jung, In Kook, et al.
Publicado: (2014)

Venous Invasion in Colorectal Cancer: Impact of Morphologic Findings on Detection Rate
por: Hwang, Chungsu, et al.
Publicado: (2016)

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
por: Kwon, Byung Su, et al.
Publicado: (2018)

Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Breast Cancers
por: Lee, So Jeong, et al.
Publicado: (2017)

Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma
por: Townsend, Katelin N., et al.
Publicado: (2013)

The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix
por: Lee, Sul, et al.
Publicado: (2020)

Prognostic value of preoperative lymphocyte-monocyte ratio in elderly patients with advanced epithelial ovarian cancer
por: Kwon, Byung Su, et al.
Publicado: (2017)

Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer
por: Leffers, N, et al.
Publicado: (2010)

Won’t you come on in? How to favor lymphocyte infiltration in tumors
por: Bellone, Matteo, et al.
Publicado: (2012)

The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma
por: Kim, Ahrong, et al.
Publicado: (2019)

Reliability of PD-L1 assays using small tissue samples compared with surgical specimens
por: Kim, Insu, et al.
Publicado: (2019)

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
por: Darb-Esfahani, Silvia, et al.
Publicado: (2015)

The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
por: Brockhoff, Gero, et al.
Publicado: (2017)

Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
por: Kim, Jung Ryul, et al.
Publicado: (2013)

High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer
por: Hong, Soon Auck, et al.
Publicado: (2020)

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
por: Dai, Danian, et al.
Publicado: (2021)

Evaluation of immune-biomarker expression in high-grade soft-tissue sarcoma: HLA-DQA1 expression as a prognostic marker
por: Bae, Jung Yun, et al.
Publicado: (2020)

Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas
por: Choi, Euno, et al.
Publicado: (2020)

Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma
por: Jakubowska, Katarzyna, et al.
Publicado: (2017)

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
por: Strickland, Kyle C., et al.
Publicado: (2016)

Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis
por: Wang, Ye-Min, et al.
Publicado: (2023)

Pattern of Tumor-Infiltrating Lymphocytes in Mixed Epithelial and Stromal Tumor of the Kidney: A Review of Five Cases
por: Lee, Hye Won, et al.
Publicado: (2021)

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
por: Cao, Jinfeng, et al.
Publicado: (2017)

Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
por: Yue, Huiran, et al.
Publicado: (2019)

Prognostic impact of tumor-infiltrating lymphocytes in high grade serous ovarian cancer: a systematic review and meta-analysis
por: Hao, Jiatao, et al.
Publicado: (2020)

Serous Cystic Neoplasm: Do We Have to Wait Till It Causes Trouble?
por: Hwang, Ho Kyoung, et al.
Publicado: (2011)

CD8(+ )lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
por: Liu, Shuzhen, et al.
Publicado: (2012)

Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer
por: Martinet, Ludovic, et al.
Publicado: (2012)

Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
por: Kos, Zuzana, et al.
Publicado: (2020)

FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment
por: Chae, Heejung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3qngr3hpjgbhom11p4tqaud9us